Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The 25th Annual General Meeting ("AGM") of Duopharma Biotech Berhad will be held on Thursday, 21 May 2026, at 9.00 a.m.. This meeting will be a physical meeting held at the meeting venue.
Date of Meeting
21 May 2026
Time
09:00 AM
Venue(s)
Conference Hall 1 & 2, Level 3,
Kuala Lumpur Convention Centre,
Kuala Lumpur City Centre,
50088 Kuala Lumpur
Malaysia
Date of General Meeting Record of Depositors
13 May 2026
Resolutions
1. For Information
Description
To receive the Audited Financial Statements for the financial year ended 31 December 2025 and the Reports of the Directors and Auditors thereon.
Shareholder’s Action
For Information Only
2. Ordinary Resolution 1
Description
To re-elect Datin Paduka Kartini Binti Hj Abdul Manaf who retires in accordance with Article 100 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action
For Voting
3. Ordinary Resolution 2
Description
To re-elect Datuk Wira Arham Bin Abdul Rahman who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action
For Voting
4. Ordinary Resolution 3
Description
To re-elect Dato' Adnan Hisham Bin Pawanteh who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action
For Voting
5. Ordinary Resolution 4
Description
To re-elect Dr. Sharmila A/P Ramachandran who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action
For Voting
6. Ordinary Resolution 5
Description
To re-elect Dr. Hasnita Binti Hashim who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action
For Voting
7. Ordinary Resolution 6
Description
To re-elect Encik Mohamad Idros Bin Mosin who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action
For Voting
8. Ordinary Resolution 7
Description
To approve the payment of Directors fees and Board Committee fees to each of the Non-Executive Directors for the period commencing 22 May 2026 until the conclusion of the next AGM of the Company, and further, to authorise the Directors to pay the said fees among them in such proportions and manner as the Directors may determine.
Shareholder’s Action
For Voting
9. Ordinary Resolution 8
Description
To approve the payment of benefits to the Non-Executive Directors up to an amount of RM768,000.00 for the period from 22 May 2026 until the conclusion of the next AGM of the Company.
Shareholder’s Action
For Voting
10. Ordinary Resolution 9
Description
To re-appoint Messrs. KPMG PLT as Auditors of the Company and to authorise the Directors to fix their remuneration.
Shareholder’s Action
For Voting
11. Ordinary Resolution 10
Description
To approve the Issuance of New Duopharma Biotech Shares pursuant to the Dividend Reinvestment Plan that provides the Shareholders of the Company with the Option to Elect to Reinvest their Dividend in New Duopharma Biotech Shares ("Dividend Reinvestment Plan").